key: cord-0277067-a050flha authors: Sheng, Jianpeng; Zhang, Junlei; Zhao, Yaxing; Song, Jinyuan; Tang, Jianghui; Wang, Xun; Ji, Yongtao; Wu, Jiangchao; Li, Taohong; Zhang, Hui; Tano, Vincent; Langley, Sarah Raye; Bai, Xueli; Liang, Tingbo title: Human endogenous retrovirus activation contributes to biliary atresia pathogenesis through re-education of resident macrophages date: 2022-03-14 journal: bioRxiv DOI: 10.1101/2022.03.11.483921 sha: 69b329b5348128a9a0be48260dd4e2b740c2dd91 doc_id: 277067 cord_uid: a050flha Biliary atresia (BA) is a life-threatening neonatal fibro-inflammatory disease characterized by hepatic fibrosis, cirrhosis, and end-stage liver failure. BA is also the most frequent indication of pediatric liver transplantation globally. Despite the devastating condition of BA, the pathogenesis mechanism is unknown. Viral infection has been suggested to be associated with BA, but definitive evidence to support this hypothesis is not available. To elucidate the virus-associated pathogenesis mechanism of BA and to understand the immune ecosystem, we performed single-cell transcriptomic and proteomic profiling of BA livers. We detected human endogenous virus (HERV) in infants with BA and their parents. HERV was mainly found in FOLR2+ resident macrophages, T cells, and NK cells. In addition, HERV activation re-educated the fetal-derived FOLR2+ resident macrophages, and reactive oxygen species scavenging neutrophil recruitment was impaired in patients with BA and HERV+, due to FOLR2+ resident macrophage re-education. Furthermore, we showed depletion of FOLR2+ resident macrophage and N-acetylcysteine treatment could rescue the liver damage in BA. Overall, our study revealed the HERV-associated immunopathology mechanism of BA. These results contribute to potential diagnosis and immunotherapy strategies for BA. Biliary atresia (BA) is a devastating neonatal fibro-inflammatory disease characterized by the obstruction of the extrahepatic biliary tract and the absence of normally branching intrahepatic ducts 1 . Hepatic fibrosis, cirrhosis, and end-stage liver failure are the common fatal consequences of progressive cholestatic jaundice if untreated timely. Kasai portoenterostomy is the classic operation for the condition of congenital biliary atresia performed on infants to allow for bile drainage 2 . BA is also the most frequent indication of pediatric liver transplantation globally. The development of curative treatment, to alleviate the need for surgical intervention, has been hindered due to its complexity and lack of understanding of the disease etiology and pathogenesis. The hypothesis that a virus plays a pivotal role in BA pathogenesis, put forward by Landing in 1974 3 , sheds light on the emergence of virus candidates for the initiation of BA, such as cytomegalovirus (CMV), Epstein-Barr virus (EBV), rotavirus, reovirus, etc. CMV is by far the best-investigated virus in terms of its relationship to human BA, unfortunately, the reported results have been inconclusive [4] [5] [6] . Although some cases have demonstrated there is a connection between EBV and BA, weak evidence was collected from previous studies to support the correlation [7] [8] [9] . Rates of rotavirus prevalence in BA were noted to fluctuate for both rotavirus types A and C based on the polymerase chain reaction (PCR) experiment [10] [11] [12] . Likewise, the hypothesis of reovirus responsible for the development of BA was overturned by a follow-up study 3, 13 . In line with the mentioned studies, there is also no evidence supporting viral infections triggering BA in a systematic review with 19 studies on 16 kinds of viruses 14 . Although many of these findings have been established, there are potential pitfalls of the applied method, PCR, which is highly sensitive and requires a considerable number of samples along with a strictly adjusted and finely tuned system to reduce false positives and obtain reliable and consistent results 15 . Taken together, the viral infection underlying BA pathogenesis is likely, but the relationship has not been determined. Recent advances in high-dimensional single-cell modalities provide exciting new opportunities to understand cellular and molecular diversity in healthy tissues and disease. Single-cell RNA sequencing (scRNA-seq) has the potential to enable gene expression profiling at the level of the individual cell 16 . In parallel, cytometry by time of flight (CyTOF) enable simultaneous singlecell measurement of more than 50 surface and intracellular proteins by combining metal isotope-labeled antibodies with mass spectrometry detection 17 . In a pilot study, Wang et al characterized a comprehensive liver immune landscape to understand the pathogenesis and therapeutics for BA by single-cell RNA profiling 18 , however, single-cell proteomic profiling of BA liver hasn't been performed yet and the virus-associated pathogenesis mechanism is not addressed. Therefore, we carried out a multi-omics study to decipher the contribution of pathological immune response caused by viral components at the single-cell resolution. To map the immune response of the BA ecosystem at the transcriptional and proteomic levels, we performed single-cell RNA sequencing (scRNA-seq), and cytometry by time of flight (CyTOF) on the liver biopsies from a cohort of BA patients. We discovered human endogenous virus activation was detected in the BA patients and their parents 19 and validated through immunohistochemistry (IHC), multiplex IHC (mIHC), and ELISA. Human endogenous retrovirus (HERV) was mainly found in FOLR2 + resident macrophages, T cells, and NK cells. In addition, we found the virus infection re-educated the fetal-derived FOLR2 resident macrophage. Although neutrophil was not the direct target of HERV, we found + SOD1/2 + neutrophils mediated ROS scavenging was impaired in BA due to FOLR2 + resident macrophage re-education, and depletion of FOLR2 + resident macrophage could rescue the liver tissue damage in BA. To summarize, our results reveal novel mechanistic insights into the pathogenesis of viral-associated immunological perturbations in BA and shed light on the potential diagnosis and immunotherapy strategies for BA. To generate a comprehensive immune cell atlas reflecting cellular and systemic adaptations resulting from virus infection, we integrated scRNA-seq and CyTOF tensor analysis of liver biopsies collected from a 12-patient cohort (Fig 1A and B ). All the patients enrolled had not gone through Kasai portoenterostomy and were within the ages of 3.9 to 9.4 months. In addition, a similar number of male (5) and female patients (7) were selected (Fig. 1A) . Furthermore, important disease indicators were also listed ( Fig. 1A) , such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST). The detailed clinical information was listed in Table S1 . We ultimately acquired 31,708 high-quality cells (minimum of 200 genes, maximum of 6000 genes, and < 10% mitochondrial reads per cell) from 12 samples using the 10X genomics scRNA-seq platform. The high-quality cells were integrated to eliminate batch effects using the Seurat package [20] [21] [22] . To explore the cellular composition, we distinguished cell types by graphbased clustering based on the RNA expression of cluster-specific markers and visualized by Uniform Manifold Approximation and Projection (UMAP) 23 , a novel manifold learning technique for dimension reduction (Fig. 1C ). 8 major cell populations were identified, including 6 immune cell types: T cells (characterized by expression of the CD3E gene), neutrophils (S100A8), macrophage (CD68), NK cells (GNLY), B cells (MS4A1), and DC (CD1c); and 3 non-immune cell types: hepatocytes (ALB) 24 and endothelial cells (VWF) 25 (Fig. 1C, S1A) . The cell counts of each population were presented in Figure. 1C and no single population was derived from one dominant sample (Fig. S1B) . To investigate the immune populations at the single-cell proteomic level, we also performed mass cytometry profiling of the same cohort. Notably, two antibody panels (lymphoid and myeloid) were created for this study based on many shared markers between scRNA-seq and CyTOF analysis (Fig 1B) . The lymphoid panel was built to quantify markers that identify lymphoid cells, such as T cell (CD3, CD4, and CD8), B cell (CD19, CD20, and CD138), and NK cell (CD56, CD57, and CD161), immunomodulatory molecules (PD-1) and chemokine reporters (CD127 and CCR7). The myeloid panel was designed to identify different populations of myeloid cells, such as macrophages (CD68, CD206, and CD86), granulocytes (CD15 and CD66b), and DCs (CD11c). Both panels included markers for the identification of immune cells (CD45) and proliferation (KI67), more details are in Figure 1D . 3,242,315 cells in total were included for Cy-TOF analysis after QC. To partition the cells into distinct phenotypes for such a high number of cells, we applied the SPADE clustering algorithm accompanied by Hierarchical Stochastic Neighbor Embedding (HSNE) to generate twodimensional graphs within Cytosplore software 26 . Following the scRNA-seq results, major immune cell subsets were identified ( Fig. 1E and 1F, Fig. S1C and S1D). Based on both transcriptional and proteomic profiles, we found immune cells were the majority of the BA ecosystem. More concretely, a very significant proportion of T cells, macrophages, granulocytes, and NK cells existed in the BA immune microenvironment. With the evidence linking BA development to viral infection, many questions regarding the etiology of the disease remain unanswered. To elucidate the molecular and cellular mechanisms of virus-induced pathologies of BA, we mapped scRNA-seq data onto a large database of known viral genomes to systematically scan for viral RNA in host transcriptome via Viral-Track 19 (Fig 2A) , a robust and unsupervised computational tool, in a direct mapping strategy. Employing Viral-Track on patient samples, we revealed the infection landscape of the virus and the interaction with the host. Two viral components, human endogenous retrovirus K113 (HERVK113, NC_022518) and Human parvovirus B19 (HP-B19, NC_000883), were successfully identified. 12 samples were divided into 4 subsets: 4 samples infected with HERV-K113, 1 sample with HP-B19, 1 sample detected with both HERV-K113 and HP-B19 simultaneously, the remaining 7 samples failed to be detected with any virus (Fig 2B) , which indicated HERV-K113 holds the dominant position in virus coverage analysis. HERV-K113 is the youngest and most active member of the human endogenous retroviruses of all human endogenous retroviruses known today, which is the only one that has been shown to produce viral particles 27 . Furthermore, the minor virus component identified, HP-B19, proved the application of the Viral-Track pipeline in the BA scRNA-seq dataset was specific and successful since HP virus has been detected in the liver of BA patients 28 . However, we mainly focus on HERV in this study, since the HP virus was established to be a noncausal agent of BA pathologies 28 . In addition, the distribution of detected viral reads was distinct for HERV and HP virus, compared to the bi-polarized distribution mode of HP-B19 reads in 2 samples, HERV-K113 remained stable among different HERV carrying patients (Fig 2C) . To further validate the specificity of the virus detected in BA, we performed Viral-Track for 6 HCC scRNA-seq samples. 12 detailed cell clusters were found (Fig. S2A ) and only HBV virus was detected in 4 out of the 6 samples (Fig. S2B ). Neither HERV nor HP were found in the HCC samples. To gain deeper insights into the distribution of infected cells in BA, we further analysed the enrichment of the infected cells. We observed a strong enrichment of viral reads in the liver resident immune cells, including T cells, macrophages, and NK cells (Fig 2D and E) . Subsequently, immunohistochemistry (IHC) against HERV capsid protein was performed to confirm the HERV activation in the BA patients. BA patients were separated into the HERV + and HERVgroups based on the Viral-Track results and HERV was detected in samples from the HERV + group only. On the contrary, there was no signal of HERV observed in the HERVgroup ( Fig 2F) . Furthermore, the distribution of HERV in types of cells was verified by multiple immunohistochemistry (mIHC). Major immune residents such as T cells (identified by CD3), macrophages (identified by CD68), and NK cells (identified by CD56) were positive with HERV ( Fig. 2G) , shown by mIHC. To further validate the HERV discovery in BA patients, we developed the ELISA assay for HERV-K113 capsid protein reactive antibodies (Fig. 2H) . We established an independent patient cohort with 16 patients and their parents (Table S1) . We found 7 out of 16 patients shows reactive antibodies to HERV-K113. Furthermore, within the 7 families, at least one of the parents also displayed reactive antibodies, and usually mother, against HERV-K113 (Fig. 2H ). This result suggested HERV activation was likely to be inherited from parents. Our results suggested a significant proportion of BA patients carrying HERV-K113 possibly through family heritage and HERV activation was mainly found in the immune residents including T cells, NK cells, and macrophages. Thus, T cells, NK cells, and macrophages were dissected in detail. To understand the immunopathogenesis mechanism related to HERV activation in T cells of BA, we applied tensor analysis for both scRNA-seq and Cy-TOF datasets 29 . First, we built the tensor-based on scRNA-seq and Cy-TOF datasets, respectively. The sample information, cell subset clustering information, and gene expression (scRNA-seq) or protein marker expression (Cy-TOF) information, formed a 3D "tensor". Then the tensors were decomposed and linked to virus-associated features via independent components analysis (ICA) (Fig.3A) Fine-resolution clustering of T cells revealed 7 subsets (Fig. 3B) , including CD8 + GZMB + T effector cells (cluster 0, Teff), TCRγ + γδ T cells (cluster 1, γδT). Cluster 2 (CD8 + ) and 3 (CD4 + ) cells were IL7R + KLRB + KLRG + CD27effector memory cells (Tem) [30] [31] [32] [33] . KLRB1 (CD161) defines rapidly responding effector memory T cells 30 We also performed single-cell proteomic analysis for the same cohort of patients via Cy-TOF. The T populations identified by CyTOF were clustered into 31 subsets using the PhenoGraph algorithm and embedded in two dimensions using UMAP (Fig. 3E ). 4 major T cell subsets were annotated based on the protein markers, including CD4 + T, CD8 + T, Treg, and γδ T cells ( Fig. 3E and F). Consistent with the scRNA-seq results, more Treg and γδ T cells were found in the HERV + patients (Fig. 3G ). In addition, we observed that the majority of the viral reads were detected within the Teff, γδ T cells, effector memory, and resident memory T cell subsets, but not in central memory T cells or Tregs (Fig 3H) , indicating that HERV activation might block the development of effector T cells into central memory phenotype. To delineate the feature changes of the T cell lineage associated with HERV activation status, we decomposed the scRNA-seq and CyTOF tensor and linked the decomposed factor to the viral activation status via ICA, respectively (Fig. 3A) . We divided 12 samples into the viral and nonviral groups with a ratio of 4:8 based on the detection of the HERV virus (Fig. 2B) . After tensor decomposition, we found scRNA-seq factor 3 was correlated with viral activation status significantly (Fig. 3I ). And a series of genes in various T cell subsets were identified to be associated with HERV activation (Fig. 3J ). Cholesterol 25-hydroxylase (CH25H) catalyzes the synthesis of 25HC from cholesterol. CH25H and 25HC are implicated in modulating anti-viral immunity at multiple levels 34, 35 . CH25H was found to be more expressed in Teff cells (Fig. 3K ). CRTAM was found to regulate late phase T cell polarity and effector function 36 . And we observed CRTAM enriched expression in Teff and γδ T cells (Fig. 3K ). FGFBP2 + was found to be an activation marker for effector T cells after SARS-CoV-2 infection 37 and we also found Teff cells expressed this marker as well (Fig. 3K ). All the effector T cell markers indicated their important roles in anti-HERV activation. Amphiregulin (AREG) enhances regulatory T cell-suppressive function via the epidermal growth factor receptor 38 and we found ARGE was highly expressed in the γδ T cells (Fig. 3K) , consistent with the increased frequency of Treg in HERV + BA infants (Fig. 3D ), although HERV activation in Treg cells was not found. And these results suggested increased Treg frequency was an indirect effect of HERV activation in γδ T cells. ICAM2 was found to be expressed by effector memory cells (Fig. 3K ) and involved in transendothelial migration of human effector memory T cells 39 . KLRB1 (CD161) defines rapidly effector T cells associated with improved survival in HPV16-associated tumors 30 and we observed KLRB1 was highly expressed in Tem cells (Fig. 3K ). PRDM1 (BLIMP1) enhanced the formation of effector memory CD8 + T cells during lymphocytic choriomeningitis virus (LCMV) infection, and PRDM1deficiency promoted the acquisition of central memory cell properties. We found PRDM1 was enriched in Teff and CD161 + Tem cells (Fig. 3K ). HERV associated upregulation of PRDM1 in effector memory cells might have blocked their development into central memory cells. We also noticed both CD4 + and CD8 + Tem cells expressed high levels of TNFα (Fig. 3K ). In addition, RORA was found to be highly expressed in Tem (Fig. 3K ), which promotes memory T cell formation and response to infection 40 . All these results indicated that T cells sustained Tem state after HERV activation for better anti-viral functions. Similarly, we performed tensor analysis for the Cy-TOF data. We found factor 1 of Cy-TOF tensor was correlated with viral activation status significantly (Fig. 3L ) and a series of protein markers were revealed by detailed analysis of factor 1 (Fig. 3M ). Among them, CXCR3 (Trm marker) was more expressed in viral patients while CCR7 and CD27 (Tcm markers) were more expressed in non-viral patients (Fig. 3N) , consistent with scRNA-seq results. Furthermore, scRNA-seq and Cy-TOF tensor analysis results were further validated by immunofluorescent staining. CD161 + Tem cells were more frequently detected in the viral group of patients. And AREG+γδ T and Treg cells were more frequently detected in the viral group of patients (Fig.3O ). Collectively, these data highlighted that T cell subsets shifted more to the anti-viral effector response after HERV activation, such as increase of CH25H in Teff cells, increased frequency of effector T cells, and CD161 + TNFα + Tem cells. In addition, Tregs were also increased in the viral group of patients, possibly due to enhanced AREG signal via γδ T cells. We next interrogated the HERV associated features of NK cells in BA samples. NK cell subsets annotations were refined further on basis of differences in the expression of specific markers. 8 rarefied subpopulations were distinguished (Fig 4A-B NK cell subsets could be categorized into two major compartments, CD56 + CD57 + and CD56 + CD57 low ( Fig. 4A and C). And CD56 + CD57 low NK cells (cluster 0, 1, 3, and 5), showed an increased fraction in the viral group of patients (Fig. 4D) . Furthermore, we found CD56 + CD57 low NK cells (clusters 0, 1, 3, and 5) were primary targets of HERV activation (Fig. 4E ). To further depict the importance of NK subpopulations in viral-induced immune response, we analysed the variety of subpopulation fractions between viral and non-viral groups based on Cy-TOF data as well. We discovered 18 clusters embedded in the two-dimensional UMAP diagram via the PhenoGraph re-cluster (Fig. 4F) . Consistent with the scRNA-seq results, 18 Cy-TOF NK clusters comprised two primary categories, CD56 + CD57 + and CD56 + CD57 low cells (Fig. 4G ). In addition, we also observed higher CD56 + CD57 low clusters in the viral group of patients via Cy-TOF (Fig. 4H ). Next, we wanted to illustrate the mechanism of the imbalanced NK cell distribution after HERV activation. Tensor analysis was formed for NK cells based on scRNA-seq and Cy-TOF data. We found factor 2 of the scRNA-seq tensor was significantly associated with the HERV activation ( Fig. 4I ). And further dissection of factor 2 revealed that CD56 + CD57 low NK cells CD158a (KIR2DL1) were mainly found in the CD56 + CD57 + NK subsets while CD158d (KIR2DL4) were mainly found in the CD56 + CD57 low NK subsets (Fig. 4K ). In addition, we also performed tensor analysis for the Cy-TOF data and we found Cy-TOF tensor factor 2 was positively associated with the HERV activation in NK cells (Fig. 4L ). And detailed analysis for factor 2 showed higher expression of BTLA and CXCR3 in the CD56 + CD57 low NK cells ( Fig. 4M-N) . Both BTLA and CXCR3 were shown to induce immunosuppressive NK phenotypes 52, 53 . In contrast, TNFRSF4 (CD134), GZMB, and TBX21 (TBET) were higher in the CD56 + CD57 + cells ( Fig. 4M-N ). All these 3 markers were important for the cytotoxic activities of NK cells 54, 55 . To further confirm our results based on scRNA-seq and Cy-TOF. Classical flow cytometry was performed to verify that CD56 + CD57 low NK cells expressed a higher level of CD158d. On the contrary, another type of NK cells identified by CD56 + CD57 + was detected with higher CD158a-expression (Fig. 4O) . Furthermore, CD56 + CD57 + NK cells showed a higher level of Granzyme B than CD56 + CD57 low NK cells, consistent with the CyTOF results. Collectively, the results of this exploratory scRNA-seq and Cy-TOF experiments revealed the presence of two phenotypically distinct NK cells with different immune statuses in patients with BA, and the difference of cytotoxicity was a consequence of distinct licensing factor engagement in NK cells associated with HERV activation. Considering macrophages comprised a significant portion of infected cells in BA infants, we next inspected macrophage-specific features associated with HERV activation at refined resolution. Macrophages could be further divided into 7 subsets (Fig 5A-B) , including S100A9 + macrophage (cluster 0) 56 , HLA II + macrophage (cluster 1), CD5L+ macrophage (cluster 2) 57 , KLF2 + macrophage (cluster 3) 58 , GPR183 + macrophage (cluster 4) 59 , MT1G + macrophage (cluster 5) 60,61 and CCL8 + macrophage (cluster 6) 62 . We observed the 7 macrophage subsets harboured two major categories, resident (cluster 1, 2 and 5) and infiltrating macrophages is also recognized as the marker for fetal-derived tissue-resident macrophage in the liver 60,61 . The inflammatory markers, IL1B, CXCL2, CXCL8, CD11b (encoded by ITGAM), and CCR2 were centralized in the infiltrating macrophage ( Fig S3A) . Consistent with our previous findings that liver infiltrating macrophages derived from bone marrow were mainly CD11b + in both human and mouse 63, 64 . In addition, we noticed resident macrophages were more enriched in the HERV + patients while infiltrating macrophages were more enriched in the HERVpatients (Fig. 5C ). Previously, we have shown that liver resident macrophages were derived from fetal definitive haematopoiesis 63-66 based on fate-mapping results. Single-cell lineage tracing analysis based on mitochondria 67 and genomic mutations showed that resident macrophages carried unique mutations derived from early fetal definitive haematopoiesis. And a big portion of the mutations was shared between infiltrating and resident macrophages, derived from the major definitive haematopoiesis wave ( Fig.S3B and C), consistent with our previous fate-mapping results. Viral-Track results showed that the fetal-derived tissue-resident macrophage (cluster 1 and 2) were the major targets for HERV activation 60 and infiltrating macrophage was less susceptible to HERV activation (Fig. 5D ). In addition, we also performed an in-depth phenotypical analysis of macrophage cells by mass cytometry (Fig 5E) , a total of 23 macrophage clusters were identified ( Fig 5E) . Consistent with the scRNA-seq data, the 23 clusters could be categorized into CD11b + CD68 + infiltrating macrophages and CD11 low CD68 + residents ( Fig. 5E and F ). In addition, Cy-TOF data also proved that resident macrophages were more enriched in the HERV + patients (Fig. 5G ). To unravel the HERV associated features of macrophages, tensor analysis was also formed for both scRNA-seq and Cy-TOF data. Factor 5 of the scRNA-seq tensor was positively correlated with the HERV activation and detailed analysis of factor 5 revealed several feature genes related to HERV activation in macrophage ( Fig. 5H and I). CXCL3, FCN3 enrichment was associated with HERVstatus of infiltrating macrophages (Fig. 5J ). CXCL3 might contribute to the neutrophil accumulation in the HERV -BA patients based on the CXCL3/CXCR2 neutrophilic chemotactic axis 68 . Ficolin-3 (FCN3) level was reported to be lowered in HIV patients and its close homolog, FCN2 was previously shown to confer resistance to several hepatotropic viruses 69 . It was likely that FCN3 upregulation in infiltrating macrophages confers HERV resistance as well. Similarly, MTRNR2L12, EGR3, and CYP2E1 enrichment were associated with the HERV + status of resident macrophages (Fig. 5I-J) . MTRNR2L12, an antiapoptotic lncRNA, was significantly upregulated in the severe COVID-19 patients 70 . MTRNR2L12 expression might contribute to the sustaining of resident macrophages after HERV activation. ERG3 was reported to be associated with HIV reactivation 71 , consistent with its expression in resident macrophages. And CYP2E1 was reported to attenuate the interferon antiviral response 72 , indicating the possible mechanism of HERV susceptivity of resident macrophage. We also performed tensor analysis for the Cy-TOF data and factor 2 of the tensor was positively correlated with the HERV activation (Fig. 5K) . CD163, FCGR3A, and SIGLEC-1 enrichment were associated with the HERV + status of resident macrophages ( Fig. 5L and M) . These markers were all specific to resident macrophages 65, 73, 74 and associated with retrovirus infection. While CCR3 downregulation was associated with the HERV + status of resident macrophages ( Fig. 5L and M) , consistent with the neutrophil depletion in the HERV + BA patients. Next, we wanted to explore the differences between resident and infiltrating macrophages. The DEGs were generated via comparison of resident and infiltrating macrophages and GO analysis was also performed (Fig. 5N ). We noticed resident macrophages were more specialized in the detoxification process while infiltrating macrophages was a strong neutrophil attractor and activator (Fig. 5N ). For example, the higher levels of expression of CXCL2 and CXCL8 that attract and activate neutrophils 75 , was noticed in the infiltrating macrophages (Fig. 5N) , consistent with the tensor analysis. Transcriptomic and proteomic profiling identified the resident and infiltrating macrophages. HERV activation was mainly detected in the FOLR2 + fetal-derived resident macrophages and associated with the increased frequency of resident macrophages. HERV activation within resident macrophages was associated with neutrophil recruitment chemokines deficiency. In response to many types of infection, neutrophils are thought to take on a pivotal role in shaping the immune response. As described above, HERV activation could contribute to the remodelling of neutrophils driven by macrophages. To extend our knowledge on the role of neutrophils in HERV + BA, we conducted scRNA-seq experiments relying on UMAP analysis. The delicate clustering distinguished three distinct subpopulations (Fig. 6A-B) , characterized by chemokines (CCL4L2, CXCL2, CCL3, and CCL4), calprotectin (S100A12, S100A8, and S100A9), and cytotoxic agents associated genes (NKG7, AREG, GZMB, and GNLY). The GZMB + neutrophil was also identified in the liver by us in a previous study 63 . The top 10 cluster-specific features were presented in Fig 6B. Strikingly, enormous neutrophils were accumulated in patients without viral infection (Fig 6A) . The fraction of all 3 subpopulations of neutrophils in patients with the virus was dramatically lower than the corresponding control, which was concordant with the marked imbalance distribution in UMAP (Fig 6A) . The findings were further confirmed by CyTOF data. The associated CyTOF neutrophil clusters (clusters 1,2,3 and 4 of neutrophil) demonstrated consistent accumulation trend in HERVnonviral group of patient samples ( Fig 6C) . Furthermore, we found the members of the iron/manganese superoxide dismutase family, SOD1 and SOD2, were concentrated in neutrophils, especially for SOD2 (Fig 6D) , indicating the release of reactive oxygen species (ROS), which could be cleared more efficiently in the nonviral group (Fig. 6E ) through ROS scavenging neutrophils. Neutrophil shortage might contribute to cell damage and death in HERV carrying patients 76 . To validate the ROS protection role of SOD1/2 + neutrophils in BA, we established a mouse BA model via Rhesus Rotavirus (RRV) induction (Fig. S4 ) to verify the ROS protection capacity of neutrophils. Mice injected with Rhesus Rotavirus (RRV) were administrated with anti-Ly-6G monoclonal antibody (Fig 6F) . After the administration of Ly-6G mAb, neutrophils were reduced significantly (Fig. 6F) . And the livers presented more serious fibrosis (Fig 6G) . Meanwhile, the ROS level also increased significantly compared to the RRV group via FACS and IF (Fig 6H and I) . Thus, HERV re-education of immune residents in BA patients also greatly reduced the shortlived SOD1/2 + neutrophil, thus exacerbating the tissue damage caused by ROS. Next, we planned to modulate the ecosystem of BA to alleviate liver tissue damage in BA patients. A novel Folr2-eGFP-DTR mouse strain was developed to deplete the HERV susceptible FOLR2 + macrophages (Fig. 7A ). BA model induced by RRV was established in the Folr2eGFP-DTR mouse (Fig. 7A ) and clear ablation of FOLR2 + (eGFP + ) macrophage could be observed (Fig. 7B) . Meanwhile, neutrophils were increased significantly (Fig. 7C) . As a result, neutrophil-mediated ROS protection was enhanced in the FOLR2 + macrophage depletion model and ROS level was also reduced in the RRV mediated BA model (Fig. 7D ). Significantly reduced fibrosis was observed in (Fig. 7E ). We also searched for clinically proven drugs to scavenge ROS for BA treatment. NAC is a potent antioxidant and was first approved by the FDA as a respiratory drug in 1963. It is also used to prevent serious liver damage from acetaminophen poisoning. Thus, we tested its application in the treatment of BA. NAC was administrated into RRV induced BA model mouse ( Fig. 7F) . We found NAC could wipe off the ROS in the RRV induced BA model (Fig. 7G ). In addition, liver fibrosis conditions were alleviated in the NAC treatment group (Fig. 7H) . Overall, we found BA could be potentially treated through specific macrophage modulation and NAC treatment. In this study, we constructed a bimodal single-cell atlas of immune cells from BA patients through scRNA-Seq and CyTOF. Our tensor analysis provided several new sights into BA pathogenesis. Firstly, we detected HERV in BA patients via Viral-Track, IHC and mIHC at single-cell resolution. Importantly, HERV activation could be inherited from the parent, validated by ELISA. HERV was predominantly enriched in liver resident immune cells, including FOLR2 + macrophages, T cells, and NK cells. We noticed HERV infection could reeducate the immune residents. Importantly, we found SOD1/2 + neutrophils mediated ROS scavenging was impaired in BA due to FOLR2 + fetal resident macrophage re-education, and depletion of FOLR2 + resident macrophage could rescue the tissue damage in BA. We noticed HERV activation was more frequent in the CD56 + CD57 low NK cells and associated with decreased cytotoxicity. In addition, KIR2DL1(CD158a) was mainly detected in the CD56 + CD57 + NK cells and KIR2DL4 (CD158d) was mainly detected in the CD56 + CD57 low NK cells. Our findings seemed against the CD158a inhibition role defined previously 78 Resident macrophages in the BA infants were carrying detoxification functions. We thought it might be due to the analysis was performed for the disease livers, which were collected at least several months after diagnosis and the jaundice was usually quite heavy during surgery time. The initial pathogenesis phase was likely in the gestation period, and we guess macrophage during the initial phase of BA might also contribute to bile ductal epithelial cell hyperplasia as well. In summary, our results showed HERV activation could remodel the local-host environment, contributing to impairment of ROS scavenging in BA. Consequently, our findings uncover the virus-associated mechanism of BA pathogenesis, which could provide novel insights into BA and reveal the potential of macrophage-based therapy for BA. Our results indicated HERV activation in the BA infants could be inherited from one of their parents and the application of screening strategy showcased in our manuscript could contribute to future diagnosis strategy for HERV. And our study may shed light on the important roles of HERV in other autoimmune diseases and tumours. For scavenging ROS, the mice with BA were administrated with NAC (A7250, Merck) at the dose of 300 mg/kg 4 times a week. Six-μm frozen slides were prepared from BA samples to be fixed through chilled methanol for 10 min. After blocking with SuperBlock (37515, Thermofisher), primary antibodies CD161 (ab259916, Abcam), Foxp3 (98377, Cell Signaling Technology) or AREG (ab234750, Abcam) followed with AF488 anti-rabbit secondary antibody (4412, Cell Signaling Technology) incubation. Then, slides were stained with DAPI for 5 min at RT. All immunofluorescent images were scanned via a four-laser scanning confocal microscope (Leica TCS SP8, Germany). Hematoxylin & eosin, Masson (G1340, Solarbio), and Sirius (G1470, Solarbio) staining were performed to verify BA pathology. IHC experiments were processed to detect the existence of HERV (LS-C65284, LSBio). In addition, traditional IHC detecting CK19 (ab52625, Abcam) was used to portray the malformation of bile ducts in RRV-infected BA mice. Images were captured by optical microscopy (Leica DM2500 LED, Germany). For identifying the location of HERV, multiplex IHC was performed. We adopted Opal Tissue was digested in culture medium supplemented with 0.6 mg/ml collagenase IV (17104019, Gibco) and 0.01 mg/ml DNase I (11284932001, Merck) at 37°C for 1 hour. Digested tissues were passed through a 0.4-µM cell strainer (352340, BD) to obtain single-cell suspensions, followed by centrifugation at 300 g for 5 min and resuspension in 36% Percoll (P4937, Sigma). After another round of centrifugation at 500 g for 5 min, cells were resuspended in 10 ml of blood lysis buffer (555899, BD) for 10 min at RT to remove red blood cells. After red blood cell lysis, cell suspensions were centrifuged again at 300 g for 5 min and then preincubated with 2.5 µg/ml Fc blocker (156604 for mouse, 422302 for human, BioLegend) on ice for 10 min. After that, the suspensions were further incubated with fluorochrome-labeled antibodies (Table. S2) at 4°C for 20 min. The antibody panel is listed in Supplementary Table S2 . For analysis, the samples were washed and resuspended in PBS supplemented with 2% FBS for analysis on a five-laser flow cytometer (BD Biosciences, Fortessa). The data were analysed with FlowJo software (TreeStar). We used the CellROX™ kit (C10492, Thermofisher) to detect ROS. In terms of the FACS method, liver tissues were digested to singlets firstly as the method described above. Then we incubated dissociated cells with a ROS probe followed by analysis on a flow cytometer. For the tissue imaging to detect ROS, as the method of immunofluorescence, ROS probes were incubated on tissue slides. After DAPI staining, slides were scanned by confocal microscopy. Library preparation, sequencing, and pre-processing service were provided by OE Biotech Co., Ltd (Shanghai, China). Briefly, the countess (Thermo) was used to count the concentration of the single-cell suspension. And the concentration of the single-cell suspension was adjusted to protocol to capture 5000-10,000 cells/chip position. All the remaining procedures including the library construction were performed according to the standard manufacturer's protocol. Single-cell libraries were sequenced on an Illumina NovaSeq instrument using 150 nt pairedend sequencing. The Cell Ranger 2.1.0 pipeline with the default and recommended parameters were used to process reads. FASTQs generated from Illumina sequencing output were aligned to the human reference genome (hg19) using the STAR algorithm. Gene-Barcode matrices were CyTOF data was pre-processed with FlowJo to manually gate CD45+ cell population from Flow cytometry standard (FCS) files. The resulting populations were fed to Cytosplore software 28, 29 for major cluster identification. Spanning-tree Progression Analysis of Density-normalized Events (SPADE) algorithm was applied on hyperbolic arcsinh the transformed data with a cofactor of 5, for clustering. Hierarchical Stochastic Neighbor Embedding (HSNE) was performed for dimensionality reduction. The major cluster re-clustering was performed using Unsupervised clustering was performed using the cytofkit package 70 in R software. PhenoGraph along with the default parameter was applied for sub-cluster identification. Uniform Manifold Approximation and Projection (UMAP) was employed for dimension reduction. Statistical analysis was performed by the Wilcoxon test, and a p-value less than 0.05 was considered as statistical significance. Visualization was implemented in ggplot2 71 . The expression matrix, metadata and selected cell types which at least 3 cells for each sample were processed to form a tensor with dimensions of samples * genes * cell-types. The pseudobulked data was normalized following the guideline. The ICA decomposition was performed to analyse the interesting biological variation with recommended parameters. The parameter of top factors and gene sets were determined by stability analysis. The association between samples and group was shown on the top of sample score matrix plot. The corresponding loading matrices for significant factor were generated to determine which genes from each cell type are significant associated with the target factor. The Bam file for each requested cell was extracted based on the corresponding barcode sequences. Freebayes was applied to call mutations for individual cells and the called mutations were further filtered with minimal depth of two for both reference and allele reads. The lineage profile for each sample was inferred from mutations showing in no more than 80% of all cells and no less than 20% for either Inflammatory or Resident Macrophages. Annovar was subsequently used to annotate filtered mutations. Raw data obtained from FACS was copied into GraphPad software. Statistical tests were selected based on the appropriate assumptions for the data distribution and variability characteristics. Sample data were analyzed by a two-tailed Student's t-test to identify statistically significant differences between two groups. One-way ANOVA with the Bonferroni post-test was used to identify differences among three or more groups. The data are represented as the means ± SEMs. A p-value < 0.05 indicated statistical significance. The R package "survminer" was implemented to analyze survival differences between different groups. Both the sequencing data and Cy-TOF data were deposited to the Genome Sequence Archive of Beijing Institute of Genomics, Chinese Academy of Sciences with an project accession of PRJCA007722. All data related to this work are set to be accessed upon publication. The authors declare no competing interests. C. The size, skin, and mucous membrane change between the two groups. RRV mouse is smaller and its skin and mucous become yellow. Feces of RRV mice become yellow compared to group control. Total bilirubin, AST, and ALT in serum from group RRV increase dramatically. The images of H&E, Masson, and IHC staining show the pathological change between the two groups. The information of patients (ELISA) A New Era of Laparoscopic Revision of Kasai Portoenterostomy for the Treatment of Biliary Atresia Considerations of the pathogenesis of neonatal hepatitis, biliary atresia and choledochal cyst--the concept of infantile obstructive cholangiopathy Polymerase chain reaction to detect human cytomegalovirus in livers of infants with neonatal hepatitis The perinatal infection of cytomegalovirus is an important etiology for biliary atresia in China Cytomegalovirusassociated biliary atresia: An aetiological and prognostic subgroup The association of extrahepatic bile duct atresia and neonatal Epstein-Barr virus infection Vanishing bile duct syndrome associated with chronic EBV infection Extrahepatic bile duct atresia and viral involvement Lack of evidence for rotavirus by polymerase chain reaction/enzyme immunoassay of hepatobiliary samples from children with biliary atresia Prevalence of group C rotavirus among children in Rhode Island, United States Incidence of hepatotropic viruses in biliary atresia Lack of evidence for reovirus infection in tissues from patients with biliary atresia and congenital dilatation of the bile duct Evidence for viral infection as a causative factor of human biliary atresia Evidence for Viral Induction of Biliary Atresia: A Review The technology and biology of single-cell RNA sequencing Mass cytometry: technique for real time single cell multitarget immunoassay based on inductively coupled plasma time-of-flight mass spectrometry Liver Immune Profiling Reveals Pathogenesis and Therapeutics for Biliary Atresia Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients Integrated analysis of multimodal single-cell data Comprehensive Integration of Single-Cell Data Integrating single-cell transcriptomic data across different conditions, technologies, and species Dimensionality reduction for visualizing single-cell data using UMAP Embryoid-body cells derived from a mouse embryonic stem cell line show differentiation into functional hepatocytes Willebrand factor, endothelial dysfunction, and cardiovascular disease Visual analysis of mass cytometry data by hierarchical stochastic neighbour embedding reveals rare cell types Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles Acute parvovirus B19 infection associated with fulminant hepatitis of favourable prognosis in young children scITD: Single-Cell Interpretable Tensor Decomposition CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumors KLRG1(+) Effector CD8(+) T Cells Lose KLRG1, Differentiate into All Memory T Cell Lineages, and Convey Enhanced Protective Immunity Human Vgamma9/Vdelta2 effector memory T cells express the killer cell lectin-like receptor G1 (KLRG1) Lipids in innate antiviral defense Multifaceted Functions of CH25H and 25HC to Modulate the Lipid Metabolism, Immune Responses, and Broadly Antiviral Activities Regulation of a late phase of T cell polarity and effector functions by Crtam Characteristics of SARS-CoV-2-specific cytotoxic T cells revealed by single-cell immune profiling of longitudinal COVID-19 blood samples Amphiregulin enhances regulatory T cell-suppressive function via the epidermal growth factor receptor Identification of endothelial cell junctional proteins and lymphocyte receptors involved in transendothelial migration of human effector memory CD4+ T cells Transcriptional insights into the CD8(+) T cell response to infection and memory T cell formation Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells Role of CREB transcription factor in c-fos activation in natural killer cells Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis Pax5: the guardian of B cell identity and function Role of chemokines in the biology of natural killer cells Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment A role for Ifit2 in restricting West Nile virus infection in the brain Cutting Edge: STAT1-Mediated Epigenetic Control of Rsad2 Promotes Clonal Expansion of Antiviral NK Cells Viperin Reveals Its True Function Natural killer cell immunosuppressive function requires CXCR3-dependent redistribution within lymphoid tissues BTLA/HVEM Axis Induces NK Cell Immunosuppression and Poor Outcome in Chronic Lymphocytic Leukemia Reciprocal crosstalk between dendritic cells and natural killer cells under the effects of PGE2 in immunity and immunopathology The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation Alarmin S100A9 Induces Proinflammatory and Catabolic Effects Predominantly in the M1 Macrophages of Human Osteoarthritic Synovium CD5L Promotes M2 Macrophage Polarization through Autophagy-Mediated Upregulation of ID3 The myeloid transcription factor KLF2 regulates the host response to polymicrobial infection and endotoxic shock Downregulation of GPR183 on infection restricts the early infection and intracellular replication of mycobacterium tuberculosis in macrophage Naringenin inhibits proinflammatory cytokine production in macrophages through inducing MT1G to suppress the activation of NFkappaB Single-cell sequencing of immune cells from anticitrullinated peptide antibody positive and negative rheumatoid arthritis Intestinal CD169(+) macrophages initiate mucosal inflammation by secreting CCL8 that recruits inflammatory monocytes Most Tissue-Resident Macrophages Except Microglia Are Derived from Fetal Hematopoietic Stem Cells Fetal HSCs versus EMP2s Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny Fate mapping analysis reveals a novel murine dermal migratory Langerhans-like cell population Lineage Tracing in Humans Enabled by Mitochondrial Mutations and Single-Cell Genomics A Critical Role for the CXCL3/CXCL5/CXCR2 Neutrophilic Chemotactic Axis in the Regulation of Type 2 Responses in a Model of Rhinoviral-Induced Asthma Exacerbation Expression of human ficolin-2 in hepatocytes confers resistance to infection by diverse hepatotropic viruses Long non-coding RNAs (lncRNAs) NEAT1 and MALAT1 are differentially expressed in severe COVID-19 patients: An integrated single-cell analysis Identification of proximal biomarkers of PKC agonism and evaluation of their role in HIV reactivation Alcohol metabolism increases the replication of hepatitis C virus and attenuates the antiviral action of interferon The macrophage scavenger receptor CD163 A Discrete Subset of Monocyte-Derived Cells among Typical Conventional Type 2 Dendritic Cells Can Efficiently Cross-Present The neutrophil as a cellular source of chemokines Differential effects of superoxide dismutase isoform expression on hydroperoxide-induced apoptosis in PC-12 cells Update on investigations pertaining to the pathogenesis of biliary atresia Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation The authors would like to thank Lei Ni for mouse management; Qi Chen and Meisheng Zhou for administrative help.